Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 1.020
-0.014 (-1.35%)
Aug 13, 2026, 5:29 PM CET
Diamyd Medical AB Cash Flow Statement
Financials in millions SEK. Fiscal year is September - August.
Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Net Income | -287.57 | -183.24 | -146.57 | -120.81 | -118.18 | -85.88 |
Depreciation & Amortization | 6.94 | 6.5 | 10.99 | 4.87 | 4.38 | 0.78 |
Other Adjustments | 81.5 | 7.93 | -1.51 | 6.42 | 3.05 | 0.29 |
Change in Receivables | 8.54 | -1.37 | 1.33 | 0.07 | 10.1 | -19.57 |
Changes in Accounts Payable | -7 | -4.64 | 11.72 | -1.51 | 7.43 | -5.1 |
Changes in Accrued Expenses | -0.38 | -6.89 | 8.96 | - | - | - |
Changes in Other Operating Activities | 11.66 | 12.02 | -14.1 | - | - | - |
Operating Cash Flow | -190.85 | -169.68 | -129.18 | -110.96 | -93.22 | -109.47 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -3.18 | -10.05 | -8.03 | -11.44 | -34.65 | -4.23 |
Purchases of Investments | -99.37 | -0.61 | -40.35 | -0.06 | -129.89 | -20.48 |
Proceeds from Sale of Investments | 60.2 | 27.83 | 20.38 | 39.91 | 96.64 | 157.24 |
Other Investing Activities | - | - | - | - | -8.82 | - |
Investing Cash Flow | -42.35 | 17.17 | -27.99 | 28.4 | -76.72 | 132.53 |
Long-Term Debt Issued | 7.64 | 14.37 | 14.81 | 15.87 | - | - |
Net Long-Term Debt Issued (Repaid) | 7.64 | 14.37 | 14.81 | 15.87 | - | - |
Issuance of Common Stock | 233.25 | 315.39 | 135.21 | 75.27 | 150 | 60 |
Net Common Stock Issued (Repurchased) | 233.25 | 315.39 | 135.21 | 75.27 | 150 | 60 |
Other Financing Activities | -17.16 | -13.44 | -7.73 | -4.59 | -7.85 | -3.28 |
Financing Cash Flow | 223.74 | 316.32 | 142.28 | 86.54 | 142.16 | 56.72 |
Foreign Exchange Rate Adjustments | -3.13 | 0.62 | 0.12 | 3.79 | 8.17 | 1.22 |
Net Cash Flow | -9.46 | 163.81 | -14.89 | 3.98 | -27.79 | 79.79 |
Free Cash Flow | -194.03 | -179.73 | -137.21 | -122.4 | -127.87 | -113.69 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -4711.63% | -3583.87% | -3144.04% | -3266.72% | -4946.65% | -25606.50% |
Free Cash Flow Per Share | -1.38 | -1.60 | -1.45 | -1.56 | -1.67 | -1.63 |
Levered Free Cash Flow | -267.96 | -158.47 | -127.5 | -108.29 | -126.36 | 51.51 |
Unlevered Free Cash Flow | -279.53 | -186.3 | -137.02 | -128.89 | -141.02 | -94.42 |